Articles From: Fatal accident at Rosebel to Federated Enhanced Treasury Income Fund Announces Estimated Sources of Distribution


2014/5/14
TSX: IMG NYSE: IAG TORONTO , May 14, 2014 /PRNewswire/ - IAMGOLD Corporation ("the Company") deeply regrets to report the death of an employee late yesterday at the Company's Rosebel Gold Mines N.V. (Rosebel) in Suriname.
Sign-up for Fatal accident at Rosebel investment picks
SAN DIEGO, April 23, 2014 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (Nasdaq:FATE) , a biopharmaceutical company engaged in the discovery and development of adult stem cell modulators to treat orphan diseases, announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug Application (IND) amendment to evaluate PROHEMA ® in pediatric patients undergoing hematopoietic stem cell (HSC) transplantation for the treatment of hematologic malignancies.
Sign-up for Fate Therapeutics Announces FDA Clearance of IND Amendment for Clinical Development of PROHEMA(R) in Pediatric Patients investment picks
SAN DIEGO, April 30, 2014 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (Nasdaq:FATE) , a biopharmaceutical company engaged in the discovery and development of adult stem cell modulators to treat orphan diseases, announced today that Christian Weyer, M.D., M.A.S., President and Chief Executive Officer, will present an overview of the company at the Deutsche Bank 39 th Annual Healthcare Conference in Boston, MA.
Sign-up for Fate Therapeutics to Present at Deutsche Bank 39th Annual Health Care Conference investment picks
SAN DIEGO, May 6, 2014 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (Nasdaq:FATE) , a biopharmaceutical company engaged in the discovery and development of adult stem cell modulators to treat orphan diseases, today announced that the Company will host a conference call and live audio webcast on Tuesday, May 13, 2014, at 5:00 p.m. EDT to report its first quarter 2014 financial results and to provide a corporate update.
Sign-up for Fate Therapeutics to Webcast Conference Call Reporting First Quarter 2014 Financial Results on May 13, 2014 investment picks
WARRENTON, Va.
Sign-up for Fauquier Bankshares, Inc. Declares Quarterly Dividend investment picks
2014/06/29
Readers reveal what they keep in their third buckets, including conservatively run funds, dividend-paying stocks, and real estate.
Sign-up for Favorite Long-Term Retirement Holdings investment picks
2014/5/21
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1117612&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for FBC Holding & HandTrux, LLC Ramp Up Partnership Discussions investment picks
http://media.marketwire.com/attachments/201404/TN-239806_growpod.jpg View of Actual Grow Pod at Work with Dozens of Plants http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1105853&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for FBC Holding Explores High-Tech Personal Indoor Grow System for Marijuana & Organic Planting; Executes Deal With HY-POD TEK investment picks
2014/4/29
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1110633&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for FBC Holding Sells Over 1,000,000 Units of Copper Based Sports Sleeve investment picks
FBL Financial Group, Inc. (NYSE: FFG) today announced that its Board of Directors declared a quarterly cash dividend of $0.35 per share to owners of Class A and Class B common stock.
Sign-up for FBL Financial Group Declares Quarterly Dividend investment picks
FBL Financial Group, Inc. (NYSE: FFG) will announce its first quarter 2014 earnings after the close of the market on Thursday, May 1, 2014.
Sign-up for FBL Financial Group Schedules First Quarter 2014 Earnings Release Date, Conference Call and Webcast investment picks
ARLINGTON, Va., May 14, 2014 (GLOBE NEWSWIRE) -- FBR & Co.
Sign-up for FBR Announces Addition to Healthcare Team investment picks
ARLINGTON, Va., May 5, 2014 (GLOBE NEWSWIRE) -- FBR & Co.
Sign-up for FBR Announces Energy Technology Summit investment picks
ARLINGTON, Va., April 22, 2014 (GLOBE NEWSWIRE) -- FBR & Co.
Sign-up for FBR Reports First Quarter Financial Results investment picks
ARLINGTON, Va., April 9, 2014 (GLOBE NEWSWIRE) -- FBR & Co.
Sign-up for FBR to Report First Quarter 2014 Financial Results investment picks
VALENCIA, Calif., April 1, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) voted 13 to 1 to recommend that AFREZZA ® (insulin human [rDNA origin]) Inhalation Powder be granted marketing approval by the FDA to improve glycemic control in adults with type 1 diabetes and voted 14 to 0 to recommend that AFREZZA be granted marketing approval by the FDA to improve glycemic control in adults with type 2 diabetes.
Sign-up for FDA Advisory Committee Recommends Approval of AFREZZA(R), MannKind Corporation's Investigational Drug to Treat Diabetes investment picks
2014/5/5
SHANGHAI and TAIPEI , May 5, 2014 /PRNewswire/ -- WuXi PharmaTech (NYSE: WX) and TaiMed Biologics today announced that the FDA has approved the first batch of the ibalizumab (TMB-355) drug substance and sterile drug product manufactured at WuXi's biologics facilities for ongoing treatment of patients under investigator-sponsored IND's.
Sign-up for FDA Approves Ibalizumab Manufactured by WuXi PharmaTech for Treatment of Patients on Expanded Access investment picks
Fully Implanted Device Represents New Treatment Option for Patients Unable to Use CPAP MINNEAPOLIS , May 1, 2014 /PRNewswire/ -- Inspire Medical Systems, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Inspire Upper Airway Stimulation (UAS) therapy for use in a subset of patients with moderate to severe Obstructive Sleep Apnea (OSA) who are unable to use Continuous Positive Airway Pressure (CPAP). Inspire therapy is a fully implanted neurostimulation device, the first of its kind for sleep apnea, that provides an alternative treatment that is proven, convenient and easy to use.
Sign-up for FDA Approves Inspire® Upper Airway Stimulation (UAS) Therapy for Obstructive Sleep Apnea investment picks
NEW YORK (MarketWatch) -- The U.S. Food and Drug Administration has approved a new drug by Merck (MRK) that lowers the risk of heart attacks and cardiovascular events associated with peripheral arterial disease.
Sign-up for FDA approves Merck's heart-attack prevention drug investment picks
2014/5/8
WASHINGTON (MarketWatch) -- The Federal Reserve on Thursday took a step towards strengthening limits on the size of the nation's largest financial companies.
Sign-up for Fed takes step to limit size of biggest banks investment picks
2014/4/18
UNION CITY, Calif.
Sign-up for Federal Court Grants Preliminary Approval Of Settlement In Abaxis Shareholder Lawsuit investment picks
2014/4/11
http://media.marketwire.com/attachments/200810/474298_1VERTC-D.JPG http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1106361&ProfileId=051205&sourceType=1 IRVINE, CA --
Sign-up for Federal Court Orders Preliminary Injunction on U.S. Sales of Medtronic's Infringing Transcatheter Valve investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G014996-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/4/28/11G014996/aon_hewitt_logo_red_blue_large-478048562920.jpg TORONTO, ON--(Marketwired - April 28, 2014) - The federal government's launch of discussions on a framework for Target Benefit Plans for federally regulated pensions highlights the potential of the Target Benefit approach to meet the changing needs of private- and public-sector plan sponsors and participants, says Aon Hewitt, the global human resources business of Aon plc (NYSE: AON). Announced on April 24, the federal consultation process means that almost every jurisdiction in Canada is now at least considering regulatory reform to allow for Target Benefit Plans -- an important step in providing pension stakeholders across the country with more flexibility to ensure long-term sustainability
Sign-up for Federal Government Consultation on Target Benefit Plans Highlights Importance of Pension Options for Private-Sector Plan Sponsors, Says Aon Hewitt investment picks
PITTSBURGH , April 11, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today confirmed that a federal district court has granted its request to enforce a settlement agreement between Endo Pharmaceuticals and Mylan settling patent litigation in connection with Mylan's filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Frovatriptan Succinate Tablets, 2.5 mg.
Sign-up for Federal Judge Enforces Settlement Agreement Between Mylan and Endo Regarding Generic FROVA® investment picks
OAK BROOK, Ill.
Sign-up for Federal Signal Appoints Jennifer Sherman as Chief Operating Officer investment picks
OAK BROOK, Ill.
Sign-up for Federal Signal to Host First Quarter Conference Call on May 1, 2014 investment picks
PITTSBURGH , April 30, 2014 /PRNewswire/ -- Federated Enhanced Treasury Income Fund (NYSE: FTT) today paid a distribution per share of $0.043 .
Sign-up for Federated Enhanced Treasury Income Fund Announces Estimated Sources of Distribution investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Fatal accident at Rosebel to Federated Enhanced Treasury Income Fund Announces Estimated Sources of Distribution
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry